Asia and Australasia Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021

LONDON, Dec. 17, 2016 /PRNewswire/ -- The Asia and Australasia influenza vaccines market is anticipated to reach nearly US$ 1.5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

In the Asia and Australasia influenza vaccines market, Japan accounts for majority of the market share. Japan is expected to remain the clear leader in influenza vaccines market throughout the forecasting period. China is the second leading market for influenza vaccines market with around XX% share in 2015. India and South Korea are the third and fourth leading market for influenza vaccines. Australia, Thailand, Singapore and New Zealand are the other leading market for influenza vaccines.

In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

iGATE Research report titled "Asia and Australasia Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 121 Page report contains 61 Figures and 8 Tables to present a clear picture of the influenza vaccines market landscape.

The Influenza Vaccines Market have been analyzed from 5 viewpoints:

1. Asia and Australasia Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)
3. Influenza Vaccines Brand Sales and Forecast to 2021
4. Influenza Vaccines Market - Major Deals
5. Influenza Vaccines Market - Driving Factors and Challenges

Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution

1. Japan
2. China
3. India
4. South Korea
5. Singapore
6. Hong Kong
7. Malaysia
8. Thailand
9. Indonesia
10. Australia
11. New Zealand

Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed

1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases

Download the full report: https://www.reportbuyer.com/product/4427831/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/asia-and-australasia-influenza-vaccines-market-persons-vaccinated-brand-analysis-and-forecast-to-2021-300380475.html

SOURCE ReportBuyer